PTPN2 reduces insulin resistance by inhibiting the inflammatory response of cells and the body and then plays a role in regulating the lipid metabolism disorder of the body, so it can be used as a therapeutic target for reducing atherosclerosis. The gene discussed is PTPN2; the disease is Insulin resistance.